Choroidal Neovascularization and Geographic Atrophy are Potential Complications of Early Onset Large Colloid Drusen

Ophthalmic Surg Lasers Imaging Retina. 2017 Jul 1;48(7):586-590. doi: 10.3928/23258160-20170630-11.

Abstract

The authors report a case of large colloid drusen (LCD) complicated by choroidal neovascularization (CNV) and geographic atrophy (GA). A 54-year-old man was referred to the authors' department with diagnosis of early onset retinal drusen. Multimodal imaging led to a diagnosis of LCD complicated by GA in the right eye and CNV in the left eye. The patient received a single injection of intravitreal aflibercept (Eylea; Regeneron, Tarrytown, NY) in the left eye. Six months later, best-corrected visual acuity improved to 20/25, and spectral-domain optical coherence tomography still showed absence of subretinal and intraretinal fluid. GA and CNV are possible complications of LCD, and contrary to previous beliefs, it should therefore not be considered as a benign condition. Intravitreal aflibercept could be considered as a useful treatment in cases complicated by CNV. [Ophthalmic Surg Lasers Imaging Retina. 2017;48:586-590.].

Publication types

  • Case Reports

MeSH terms

  • Choroidal Neovascularization / diagnosis
  • Choroidal Neovascularization / drug therapy
  • Choroidal Neovascularization / etiology*
  • Fluorescein Angiography / methods
  • Follow-Up Studies
  • Fundus Oculi
  • Geographic Atrophy / complications
  • Geographic Atrophy / drug therapy
  • Geographic Atrophy / etiology*
  • Humans
  • Intravitreal Injections
  • Male
  • Middle Aged
  • Receptors, Vascular Endothelial Growth Factor / administration & dosage
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors
  • Recombinant Fusion Proteins / administration & dosage
  • Retinal Drusen / complications*
  • Retinal Drusen / diagnosis
  • Retinal Drusen / drug therapy
  • Time Factors
  • Tomography, Optical Coherence / methods
  • Visual Acuity

Substances

  • Recombinant Fusion Proteins
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor